Zydus prepares to roll out the first and only needle-free vaccine. It is India’s first recombinant, DNA based vaccine developed indigenously in its labs.
Managing Director Dr Sharvil Patel speaks to Fortune India on life turned on its head by Covid-19 and the company's focus on innovation after vaccine development.
Fortune India is now on WhatsApp! Get the latest updates from the world of business and economy delivered straight to your phone. Subscribe now.